<DOC>
	<DOCNO>NCT00960258</DOCNO>
	<brief_summary>This study define pharmacokinetics evaluate safety BAY73-4506 , 160 mg daily administer orally single agent Japanese patient advance solid tumor .</brief_summary>
	<brief_title>Phase I Study Investigate Pharmacokinetics Safety BAY73-4506 Asian ( Japanese ) Patients With Solid Tumors .</brief_title>
	<detailed_description />
	<criteria>Male female Japanese patient &gt; /= 18 year Histologically cytologically confirm solid tumor ECOGPS 0 1 Adequate bone marrow , liver renal function Uncontrolled hypertension Patients severe renal impairment dialysis Patients seizure disorder require anticonvulsant medication Known suspect allergy investigational agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Solid Tumors</keyword>
</DOC>